Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Virtual walking program to reduce chronic neuropathic pain after spinal cord injury

Official title: Virtual Walking With Habitual Feedback to Reduce Chronic Neuropathic Pain in Individuals With Spinal Cord Injury

Run by Swiss Paraplegic Research, Nottwil · NCT07165353 · Data updated 2026-11-12

This project will test whether virtual walking from different visual perspectives can reduce long-lasting neuropathic pain and improve quality of life for adults living with chronic spinal cord injury.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorSwiss Paraplegic Research, Nottwil
Research network
Locations1 site (Nottwil, Canton of Lucerne)
StatusRecruiting
StartedJanuary 20, 2026
Main results expectedNovember 30, 2027
Study endsNovember 30, 2027
Registry record updatedJanuary 21, 2026
Trial IDNCT07165353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are German-speaking adults (18–75) at least six months after traumatic or non‑traumatic SCI with clinician-diagnosed neuropathic pain of 4/10 or higher affecting the trunk or lower limbs.

Probably not a fit

Patients with predominantly nociceptive pain, very recent injuries (<6 months), the ability to walk more than five minutes without aids, serious uncontrolled psychiatric illness, or who are pregnant are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized interventional trial at the Schweizer Paraplegiker Zentrum in Nottwil will compare virtual walking delivered from different visual perspectives to a sham virtual walking condition in adults with chronic neuropathic pain after spinal cord injury. Participants aged 18–75 with traumatic or non‑traumatic SCI at least six months earlier and neuropathic pain of at least 4/10 will be randomized to receive virtual walking sessions or a sham intervention over a defined training period. Outcomes include changes in pain intensity and quality of life, and mechanistic measures such as quantitative sensory testing (QST) and contact heat-evoked potentials (CHEPs) to probe sensory and cortical changes. People who can walk more than five minutes without aids, have serious uncontrolled psychiatric conditions, or are pregnant will be excluded.

Why it matters

Potential benefit: If successful, the intervention could offer a non-drug way to reduce neuropathic pain and improve daily functioning and quality of life for people with chronic SCI.

How similar studies have gone: Previous small trials and pilot studies of virtual reality, motor imagery, and visual feedback for neuropathic pain have shown promising but mixed results, so this approach has preliminary support but is not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sufficient knowledge of German language to understand the instructions, assessments and to fill in questionnaires.
* Age ≥ 18y, ≤ 75y
* Chronic traumatic or non-traumatic SCI (\>6 month after SCI) with an SCI severity grade AIS A, B, C or D
* At or below level spinal cord injury neuropathic pain on trunk or lower extremities diagnosed by a neurologist following the ISCIP classification (Bryce et al., 2012) of at least 4/10 intensity on a NRS (Langford et al., 2023)
* Ability to draw with a pen

Exclusion Criteria:

* \- Serious psychiatric disorders, which are accompanied by imminent or current acute harm to oneself or others, or which require inpatient psychiatric treatment for other reasons, or other indications of a foreseeable, seriously harmful effect of participation in the study based on the clinical impression from the psychological screening interview
* Participants with a walking ability more than 5 minutes without walking aids
* Pregnancy (anamnestic) in women of child-bearing age (18-49 years)
* Known epilepsy
* neurological disorders (multiple sclerosis, ALS, Guillan-Barré Syndrome, congenital disorders, polyneuropathy)

Where it's running

  • Schweizer Paraplegiker Zentrum Nottwil
    Nottwil, Canton of Lucerne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.